EC Number |
Inhibitors |
Structure |
---|
1.14.11.9 | (+)-dihydrokaempferol |
product inhibition |
|
1.14.11.9 | 3-Bromo-2-oxoglutarate |
1 mM 92% inhibition |
|
1.14.11.9 | 3-hydroxy-5-oxo-4-butyryl-cyclohex-3-ene-1-carboxylic acid ethyl ester |
1 mM 36% relative activity, 0.1 mM 68% relative activity |
|
1.14.11.9 | 3-hydroxy-5-oxo-4-cyclopropanecarbonyl-cyclohex-3-ene-1-carboxylic acid ethyl ester |
1 mM 9% relative activity, 0.1 mM 38% relative activity |
|
1.14.11.9 | 3-hydroxy-5-oxo-4-propionyl-cyclohex-3-ene-1-(2-dimethylamino)-thiazole |
1 mM 25% relative activity, 0.1 mM 56% relative activity |
|
1.14.11.9 | 3-hydroxy-5-oxo-4-propionyl-cyclohex-3-ene-1-carbaldehyde |
1 mM 33% relative activity, 0.1 mM 75% relative activity |
|
1.14.11.9 | 3-hydroxy-5-oxo-4-propionyl-cyclohex-3-ene-1-carbothioic acid S-ethyl ester |
1 mM 15% relative activity, 0.1 mM 40% relative activity |
|
1.14.11.9 | 3-hydroxy-5-oxo-4-propionyl-cyclohex-3-ene-1-pentanoic acid |
1 mM 13% relative activity, 0.1 mM 75% relative activity |
|
1.14.11.9 | benzene-1,2,4,5-tetracarboxylic acid |
1 mM 95% relative activity |
|
1.14.11.9 | calcium 3-hydroxy-5-oxo-4-propionyl-cyclohex-3-ene-1-carboxylate |
1 mM 10% relative activity, 0.1 mM 33% relative activity |
|